Form 4 for AGL agilon health, inc.
Accepted 2022-04-21 00:00:00 ET · period of report 2022-04-19 · accession 0001209191-22-025160 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| DM | 2022-04-21 | 2022-04-19+ | AGL | Desai Veeral | Chief Strategy, Dev. Off | M - OptEx | $1.00 | +212.7K | 384.6K | +124% | +$212.7K |
| DM | 2022-04-21 | 2022-04-19+ | AGL | Desai Veeral | Chief Strategy, Dev. Off | S - Sale+OE | $22.54 | -212.7K | 278.2K | -43% | -$4.79M |
| DM | 2022-04-21 | 2022-04-19+ | AGL | Desai Veeral | Chief Strategy, Dev. Off | M - OptEx | $0.00 | -212.7K | 775.4K | -22% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2022-04-19 | M | A | 106,357 | $1.00 | 384,568 | D | — | — | (F1) Includes restricted stock units. |
| 2 | Common | Common Stock | 2022-04-19 | S | D | 106,357 | $22.74 | 278,211 | D | — | — | (F3) The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions ranging from $21.90 to $23.05, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth above. (F1) Includes restricted stock units. |
| 3 | Common | Common Stock | 2022-04-20 | M | A | 106,357 | $1.00 | 384,568 | D | — | — | (F1) Includes restricted stock units. |
| 4 | Common | Common Stock | 2022-04-20 | S | D | 106,357 | $22.34 | 278,211 | D | — | — | (F4) The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions ranging from $21.76 to $22.93, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth above. (F1) Includes restricted stock units. |
| 5 | Derivative | Options (Rights to Buy) | 2022-04-20 | M | D | 106,357 | $0.00 | 668,994 | D | $1.00 · — to 2027-04-27 | 106,357 Common Stock | (F5) These options were granted on April 27, 2017 and fully vested on April 27, 2021. |
| 6 | Derivative | Options (Rights to Buy) | 2022-04-19 | M | D | 106,357 | $0.00 | 775,351 | D | $1.00 · — to 2027-04-27 | 106,357 Common Stock | (F5) These options were granted on April 27, 2017 and fully vested on April 27, 2021. |